Crescent Biopharma to Present at November Investor Conferences
Globe Newswire•02/11/2026•07:30 ET
0
Key Highlights
- ➤Crescent Biopharma (CBIO) schedules three November investor conference fireside chats
- ➤Presentations span Guggenheim, Stifel, and Jefferies healthcare conferences
- ➤Lead pipeline includes a PD-1 x VEGF bispecific antibody
- ➤Clinical-stage pipeline also includes novel antibody-drug conjugates (ADCs)
WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November: * Guggenheim 3rd Annual Healthcare Innovation Conference, fireside chat on Monday, November 9, 2026 at 8:30 a.m. ET in Boston.
* Stifel 2026 Healthcare Conference, fireside chat on Tuesday, November 10, 2026 at 1:20 p.m. ET in New York.
Get started
Create a free account to read the full story.